<DOC>
	<DOCNO>NCT00267657</DOCNO>
	<brief_summary>In parallel group clinical pharmacology laboratory experiment , assess pharmacodynamic interaction ( focus cardiovascular effect ) 15 mg intravenous methamphetamine dose single oral dos reserpine ( 0.5 1.0 mg ) placebo .</brief_summary>
	<brief_title>A Phase 1 Parallel-Group , Double-Blind , Placebo-Controlled Cardiovascular Behavioral Study Assessing Interactions Between Single Doses Oral Reserpine Intravenous Methamphetamine - 1</brief_title>
	<detailed_description>In parallel group clinical pharmacology laboratory experiment , assess pharmacodynamic interaction ( focus cardiovascular effect ) 15 mg intravenous methamphetamine dose single oral dos reserpine ( 0.5 1.0 mg ) placebo .</detailed_description>
	<mesh_term>Amphetamine-Related Disorders</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<mesh_term>Reserpine</mesh_term>
	<criteria>Please contact site detail Please contact site detail</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2005</verification_date>
</DOC>